# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-25-043574
Filing Date
2025-05-01
Accepted
2025-05-01 17:20:49
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-05-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | tm254297d2_ars.pdf | ARS | 1396665
| Complete submission text file | 0001104659-25-043574.txt |  | 1923257

Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39202 | Film No.: 25904420
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)